Bristol-Myers to Acquire Celgene in Deal Worth $74 Billion
Thursday, January 3, 2019 - 09:40
in Mathematics & Economics
Together, the merged companies would have nine pharmaceutical products with more than $1 billion in annual sales. The deal is expected to be completed in the third quarter.